Haemonetics HAE
NYSE HAE
$100.90 -2.26 (-2.19%)
As of: Sep 10, 2026 · 3:26 PM EDT

Haemonetics (HAE) Gross Profit Growth (3y) (2012 - 2026)

Analysis

Haemonetics (HAE) Gross Profit Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (3y) (Qtr)
1 Abbott Laboratories 180.08 Bn 174.48 Bn 7.27 Bn 9.77%
2 Intuitive Surgical 127.86 Bn 122.64 Bn 1.96 Bn 18.71%
3 Medtronic 117.15 Bn 108.33 Bn 6.34 Bn 7.71%
4 Stryker 103.82 Bn 100.34 Bn 4.50 Bn 12.24%
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 14.82%
6 Edwards Lifesciences 49.76 Bn 45.51 Bn 1.35 Bn 9.36%
7 Alcon 32.95 Bn 31.49 Bn 1.68 Bn 7.11%
8 Dexcom 32.22 Bn 30.27 Bn 830.00 Mn 14.95%
9 Steris 20.71 Bn 20.23 Bn 684.20 Mn 8.95%
10 Haemonetics 4.58 Bn 4.36 Bn 202.80 Mn 6.63%
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 6.63%
Mar 28, 2026 8.25%
Dec 27, 2025 8.44%
Sep 27, 2025 7.25%
Jun 28, 2025 10.56%
Mar 29, 2025 12.30%
Dec 28, 2024 11.78%
Sep 28, 2024 15.22%
Jun 29, 2024 17.41%
Mar 30, 2024 29.07%
Dec 30, 2023 13.94%
Sep 30, 2023 17.26%
Jul 1, 2023 22.93%
Apr 1, 2023 11.22%
Dec 31, 2022 7.42%
Oct 1, 2022 7.52%
Jul 2, 2022 7.07%
Apr 2, 2022 7.02%
Jan 1, 2022 7.62%
Oct 2, 2021 3.07%